| scholarly article | Q13442814 |
| P2093 | author name string | J. D. Minna | |
| Y. Sekido | |||
| K. M. Fong | |||
| P2860 | cites work | Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21 WAF1 | Q22299424 |
| Familial risk of lung cancer among nonsmokers and their relatives | Q23923032 | ||
| Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines | Q24303652 | ||
| Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3 that is homozygously deleted in a lung carcinoma cell line | Q24309163 | ||
| hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization | Q24310670 | ||
| Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns | Q24311901 | ||
| The rearranged L-myc fusion gene (RLF) encodes a Zn-15 related zinc finger protein | Q24314868 | ||
| Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer | Q24319164 | ||
| BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression | Q24321439 | ||
| Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis | Q24561466 | ||
| 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region | Q24650774 | ||
| Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer | Q69373028 | ||
| Overexpression of oncoproteins in non-small cell lung carcinomas of smokers | Q70459086 | ||
| Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations | Q70466865 | ||
| Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients | Q70472514 | ||
| Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines | Q70786926 | ||
| Sequential molecular genetic changes in lung cancer development | Q70851318 | ||
| Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines | Q70866395 | ||
| Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer | Q70866448 | ||
| Alterations of CDKN2 (p16) in non-small cell lung cancer | Q70970949 | ||
| Microsatellite instability in primary and metastatic lung carcinomas | Q71010040 | ||
| K-ras oncogene activation in atypical alveolar hyperplasias of the human lung | Q71046892 | ||
| Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study | Q71058135 | ||
| Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers | Q71081134 | ||
| Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers | Q71093043 | ||
| p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation | Q71124144 | ||
| Tumor induction and tissue atrophy in mice lacking E2F-1 | Q71129252 | ||
| Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers | Q71184934 | ||
| Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer | Q71254262 | ||
| Lung tumors in mice expressing an antisense RARbeta2 transgene | Q71520382 | ||
| Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas | Q71566389 | ||
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 | Q71644976 | ||
| Expression of bcl-2--protein in small cell lung cancer | Q71671044 | ||
| Allelic losses in human chromosome 11 in lung cancers | Q71700579 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Mutation of a mutL homolog in hereditary colon cancer | Q28114939 | ||
| A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer | Q28116430 | ||
| Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer | Q28235895 | ||
| An achaete-scute homologue essential for neuroendocrine differentiation in the lung | Q28236555 | ||
| The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 | ||
| Functional significance of different human CYP1A1 genotypes | Q28243236 | ||
| Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor | Q28251328 | ||
| DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 | Q28254119 | ||
| Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest | Q28270478 | ||
| Altered cJUN expression: an early event in human lung carcinogenesis | Q28272085 | ||
| Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG | Q28276270 | ||
| Mutation analysis of the PTEN/MMAC1 gene in lung cancer | Q28287144 | ||
| Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein | Q28305440 | ||
| Opioids induce while nicotine suppresses apoptosis in human lung cancer cells | Q28306814 | ||
| Bax suppresses tumorigenesis and stimulates apoptosis in vivo | Q28506493 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers | Q29616471 | ||
| Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours | Q29618396 | ||
| Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons | Q29618538 | ||
| Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF | Q29619663 | ||
| Isolation of DNA sequences deleted in lung cancer by genomic difference cloning | Q33191672 | ||
| A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma | Q33509666 | ||
| Replacement of Fhit in cancer cells suppresses tumorigenicity | Q33726007 | ||
| A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding | Q33779824 | ||
| Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. | Q33825340 | ||
| Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin | Q33968610 | ||
| C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. | Q34124421 | ||
| v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line | Q34252335 | ||
| Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. | Q34295864 | ||
| Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer | Q34348374 | ||
| Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin | Q34382506 | ||
| Microsatellite alterations in plasma DNA of small cell lung cancer patients. | Q34394739 | ||
| Cigarette Smoking and Changes in the Histopathology of Lung Cancer | Q38503712 | ||
| Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer | Q39714055 | ||
| Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines | Q39992153 | ||
| Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer | Q40016745 | ||
| Lung Cancer and CYP2D6 (the debrisoquine polymorphism): sources of heterogeneity in the proposed association | Q40426573 | ||
| Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer | Q40678571 | ||
| Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis | Q40694250 | ||
| Protein Expression and Functional Analysis of the FHIT Gene in Human Tumor Cells | Q41055843 | ||
| Conversion of Bcl-2 to a Bax-like Death Effector by Caspases | Q41073693 | ||
| p73 is a simian [correction of human] p53-related protein that can induce apoptosis | Q41091013 | ||
| Effect of cohort differences in smoking prevalence on models of lung cancer susceptibility | Q41096228 | ||
| Retinoids in lung development. | Q41108334 | ||
| Involvement of signal transduction pathways in lung cancer biology. | Q41111794 | ||
| Three distinct regions involved in 3p deletion in human lung cancer | Q41123112 | ||
| Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions | Q41133775 | ||
| Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer | Q41167050 | ||
| Deletion mapping of chromosome 2 in human lung carcinoma | Q41193680 | ||
| Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage | Q41273144 | ||
| Basic science of small cell lung cancer | Q41321254 | ||
| Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer | Q41332396 | ||
| Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer | Q41362569 | ||
| In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers | Q41373277 | ||
| Bombesin-like peptides and airway repair: a recapitulation of lung development? | Q41384707 | ||
| Stem cells in lung development, disease, and therapy | Q41442268 | ||
| A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes | Q41451226 | ||
| Myc target genes | Q41491682 | ||
| Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting | Q41503197 | ||
| Non-small cell lung cancer: clinical value of new biological predictors | Q41523353 | ||
| Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody. | Q41524948 | ||
| A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity | Q41543902 | ||
| The interaction of Ras with GTPase‐activating proteins | Q41554070 | ||
| The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions | Q41554100 | ||
| Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells | Q41558427 | ||
| Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. | Q41559408 | ||
| Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene | Q41564993 | ||
| Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: a strategy for cloning the putative tumor suppressor gene | Q41605894 | ||
| Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation | Q41612390 | ||
| Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020 | Q41616459 | ||
| Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines | Q41623159 | ||
| Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer | Q41633055 | ||
| Implication of RARB in epidermoid (Squamous) lung cancer | Q41668039 | ||
| Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors | Q41952934 | ||
| Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression | Q42050081 | ||
| Induction of Apoptosis in Small-Cell Lung Cancer Cells by an Antisense Oligodeoxynucleotide Targeting the Bcl-2 Coding Sequence | Q42441665 | ||
| Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas | Q42479975 | ||
| bcl-2 protein in non-small-cell lung carcinoma | Q42508274 | ||
| Bombesin receptor structure and expression in human lung carcinoma cell lines. | Q42638221 | ||
| The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21. | Q42651150 | ||
| Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County | Q43762018 | ||
| Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence | Q44344425 | ||
| Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung | Q45037436 | ||
| Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer | Q45066172 | ||
| Increased familial risk for lung cancer | Q45220819 | ||
| Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas | Q45345804 | ||
| Impaired lung branching morphogenesis in the absence of functional EGF receptor | Q46117988 | ||
| Identification of novel regions of altered DNA copy number in small cell lung tumors | Q46229352 | ||
| The p19INK4D Cyclin dependent kinase inhibitor gene is altered in osteosarcoma | Q46665639 | ||
| Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor | Q46766121 | ||
| Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance | Q50626711 | ||
| Cigarettes, Sex, and Lung Adenocarcinoma | Q50925655 | ||
| Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma | Q50944026 | ||
| Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer | Q50950104 | ||
| Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B. | Q50960351 | ||
| High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage | Q52192163 | ||
| The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis | Q52892865 | ||
| Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations | Q53001345 | ||
| Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles. | Q53442031 | ||
| Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk | Q53442109 | ||
| Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions | Q53443601 | ||
| Mutation analysis of the coding sequences of MEK-1 and MEK-2 genes in human lung cancer cell lines | Q53445143 | ||
| Influence of a mutation reducing the catalytic activity of the cytochrome P450 CYP2D6 on lung cancer susceptibility. | Q53450800 | ||
| The FHIT gene 3p14.2 is abnormal in lung cancer | Q53455201 | ||
| Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers | Q53456376 | ||
| Genetic component of lung cancer: cohort study of twins | Q53470574 | ||
| Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer | Q53494420 | ||
| Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung | Q53497397 | ||
| Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells | Q54172826 | ||
| Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations | Q54238137 | ||
| Antitumor Activity of a Monoclonal Antibody Directed Against Gastrin-Releasing Peptide in Patients With Small Cell Lung Cancer | Q54550898 | ||
| p16/CDKN2 gene and p53 gene alterations in Japanese non-smoking female lung adenocarcinoma. | Q55317409 | ||
| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
| Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer | Q57254237 | ||
| Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer | Q58068871 | ||
| Repression of RNA polymerase III transcription by the retinoblastoma protein | Q58450660 | ||
| Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinoma | Q58454752 | ||
| Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma | Q58454772 | ||
| Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer | Q59079930 | ||
| Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study | Q59219589 | ||
| High frequency of retinoic acid receptor beta abnormalities in human lung cancer | Q67701783 | ||
| Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme μ | Q67753826 | ||
| The ras gene family in human non-small-cell lung cancer | Q67860660 | ||
| p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus | Q67911122 | ||
| Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung | Q68082107 | ||
| Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions | Q68090482 | ||
| ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis | Q68119388 | ||
| Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters | Q68254096 | ||
| ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent | Q68254101 | ||
| Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells | Q68304765 | ||
| K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung | Q68532141 | ||
| Evidence for mendelian inheritance in the pathogenesis of lung cancer | Q68861237 | ||
| Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer | Q73081849 | ||
| bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis | Q73090126 | ||
| In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility | Q73154991 | ||
| Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity | Q73272342 | ||
| Retinoic acid receptor expression abnormalities in lung cancer: important clues or major obstacles? | Q73337245 | ||
| Association of p53 protein expression in stage I lung adenocarcinoma with reference to cytological subtypes | Q73354557 | ||
| Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors | Q73424545 | ||
| Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung | Q73436889 | ||
| The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung | Q73443635 | ||
| Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors | Q73507959 | ||
| Immunocytochemical markers in stage I lung cancer: relevance to prognosis | Q73585186 | ||
| Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas | Q73634108 | ||
| The prognostic significance of p53 andbcl-2 expression in lung adenocarcinoma and its correlation with ki-67 growth fraction | Q73717517 | ||
| Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types | Q74480207 | ||
| Differential expression of the retinoblastoma gene family members pRb/p105, p107, and pRb2/p130 in lung cancer | Q77557324 | ||
| Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. | Q34399850 | ||
| Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas | Q34423364 | ||
| Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development | Q34426069 | ||
| Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer | Q34436736 | ||
| Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects | Q34623003 | ||
| Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo | Q35227133 | ||
| Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer | Q35477427 | ||
| Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer | Q35666693 | ||
| Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications | Q35764748 | ||
| Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation | Q35774292 | ||
| Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance | Q35782638 | ||
| Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma | Q35807817 | ||
| Microsatellite alterations as clonal markers for the detection of human cancer | Q35819311 | ||
| Familial Aggregation of Lung Cancer among Hospital Patients | Q35883237 | ||
| Mutations and altered expression of p16INK4 in human cancer. | Q35892778 | ||
| Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. | Q35966914 | ||
| Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts | Q35975907 | ||
| Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein | Q35978507 | ||
| Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer | Q36080901 | ||
| Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells | Q36084691 | ||
| A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers | Q36116177 | ||
| Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma | Q36134259 | ||
| Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer | Q36134480 | ||
| Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer | Q36134992 | ||
| Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections | Q36135626 | ||
| Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. | Q36136355 | ||
| MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer | Q36136459 | ||
| Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma | Q36243414 | ||
| Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases | Q36367319 | ||
| Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p | Q36419914 | ||
| Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients | Q36422016 | ||
| Vascular endothelial growth factor and lymph node metastasis in primary lung cancer | Q36431274 | ||
| Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression | Q36431673 | ||
| MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation | Q36431703 | ||
| Non-ocular cancer in relatives of retinoblastoma patients | Q36467625 | ||
| High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene | Q36760672 | ||
| Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer | Q36793456 | ||
| Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo | Q36864271 | ||
| Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer | Q36869755 | ||
| Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1 | Q36920336 | ||
| Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice | Q37356393 | ||
| Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products | Q37599429 | ||
| Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells | Q37734603 | ||
| Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas | Q38305358 | ||
| Microsatellite Instability in Lung Cancer Patients 40 Years of Age or Younger | Q38345275 | ||
| Insulin-like growth factor expression in human cancer cell lines | Q38357885 | ||
| Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas | Q38474361 | ||
| Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study | Q38476276 | ||
| Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients | Q38479399 | ||
| Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers | Q38480210 | ||
| K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas | Q38482358 | ||
| Immunohistochemical detection of basic fibroblast growth factor as a prognostic indicator in pulmonary adenocarcinoma | Q71733817 | ||
| High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs | Q71743702 | ||
| Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape | Q71762882 | ||
| Serum p53 antibodies as early markers of lung cancer | Q71803498 | ||
| Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer | Q71814416 | ||
| DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies | Q71814434 | ||
| Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers | Q71820098 | ||
| Molecular basis for lack of expression of HLA class I antigens in human small-cell lung carcinoma cell lines | Q71821499 | ||
| Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation | Q71834681 | ||
| Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? | Q71840957 | ||
| Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma | Q71862654 | ||
| Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders | Q71878642 | ||
| Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity | Q71909474 | ||
| Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines | Q71909478 | ||
| Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers | Q71909483 | ||
| Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene | Q71955532 | ||
| A hereditary genetic marker closely associated with microsatellite instability in lung cancer | Q72033731 | ||
| Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers | Q72038585 | ||
| Human Lung Carcinogen--DNA Adduct Levels Mediated by Genetic Polymorphisms In Vivo | Q72038588 | ||
| Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung | Q72079143 | ||
| Deletion mapping of the short arm of chromosome 8 in non‐small cell lung carcinoma | Q72087895 | ||
| Altered imprinting in lung cancer | Q72116903 | ||
| Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers | Q72119659 | ||
| Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases | Q72223794 | ||
| Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies | Q72255920 | ||
| Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma | Q72365281 | ||
| Microsatellite instability and other molecular abnormalities in non-small cell lung cancer | Q72368568 | ||
| Genetic instability of microsatellite sequences in many non-small cell lung carcinomas | Q72399771 | ||
| Frequent microsatellite instability in primary small cell lung cancer | Q72399781 | ||
| Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer | Q72610940 | ||
| Absence of activating mutations of the RAF1 protooncogene in human lung cancer | Q72625361 | ||
| Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb | Q72650504 | ||
| Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome | Q72657543 | ||
| c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties | Q72680125 | ||
| Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma | Q72710470 | ||
| Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung | Q72710475 | ||
| Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB | Q72744200 | ||
| Frequent loss of chromosome 9 in human primary non-small cell lung cancer | Q72769107 | ||
| Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23) | Q72916321 | ||
| Neuroendocrine tumors of the lung. Pathology and molecular biology | Q72992626 | ||
| Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer | Q73023156 | ||
| Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer | Q73023180 | ||
| Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas | Q73027878 | ||
| Rare alleles at different VNTR loci among lung-cancer patients with microsatellite instability in tumours | Q73074308 | ||
| Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer | Q73081843 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | F21-59 | |
| P577 | publication date | 1998-08-01 | |
| 1998-08-19 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Progress in understanding the molecular pathogenesis of human lung cancer | |
| P478 | volume | 1378 |
| Q37702708 | Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer |
| Q40625644 | Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression |
| Q37330746 | Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study |
| Q90095282 | Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India) |
| Q37758841 | Biochemical and docking analysis of substrate interactions with polyisoprenylated methylated protein methyl esterase |
| Q24649650 | Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung |
| Q34572870 | Cigarette smoking: cancer risks, carcinogens, and mechanisms |
| Q35028440 | Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans |
| Q37940375 | DNA Methylation and Nonsmall Cell Lung Cancer |
| Q36471888 | DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer. |
| Q40796958 | Defective caspase-3 relocalization in non-small cell lung carcinoma. |
| Q34997440 | Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues |
| Q33705017 | Distinct Epigenetic Domains Separated by a CTCF Bound Insulator between the Tandem Genes, BLU and RASSF1A |
| Q36261852 | Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer |
| Q37205334 | EGFR and KRAS mutations in patients with adenocarcinoma of the lung |
| Q51794333 | EGFR point mutation in non-small cell lung cancer is occasionally accompanied by a second mutation or amplification |
| Q24291194 | Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression |
| Q39395200 | Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients |
| Q43955981 | Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers |
| Q34935982 | Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer |
| Q24621422 | Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2) |
| Q40791017 | Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion |
| Q28360366 | Global methylation profiling of lung cancer identifies novel methylated genes |
| Q40876361 | Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer |
| Q34792237 | Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin |
| Q33194582 | Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non‐small cell lung cancer |
| Q33972805 | Lung cancer * 9: Molecular biology of lung cancer: clinical implications |
| Q38465535 | M6P/IGF2R is mutated in squamous cell carcinoma of the lung |
| Q24610335 | Molecular biology of lung cancer: clinical implications |
| Q37511952 | Molecular changes in the bronchial epithelium of patients with small cell lung cancer |
| Q30782803 | Molecular characteristics of non-small cell lung cancer |
| Q43955974 | Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workers |
| Q34249055 | Molecular genetic abnormalities in the pathogenesis of human lung cancer |
| Q26999068 | Mouse Models for Efficacy Testing of Agents against Radiation Carcinogenesis — A Literature Review |
| Q26747129 | Mouse models for radiation-induced cancers |
| Q23909570 | Mutational activation of the MAP3K8 protooncogene in lung cancer |
| Q44039872 | Occurrence of H-ras codon 61 CAA to AAA mutation during mouse liver tumor progression. |
| Q37388731 | Overexpression of Pygopus-2 is required for canonical Wnt activation in human lung cancer |
| Q64085185 | Ovine Pulmonary Adenocarcinoma: A Unique Model to Improve Lung Cancer Research |
| Q37681630 | PPAR Agonists for the Prevention and Treatment of Lung Cancer |
| Q28068114 | PPARγ as a Novel Therapeutic Target in Lung Cancer |
| Q36359174 | Parallel assessment of CpG methylation by two-color hybridization with oligonucleotide arrays |
| Q36417658 | Peroxisome proliferator-activated receptors in lung cancer. |
| Q73362892 | Pleomorph poorly differentiated endocrine carcinoma of the rectum |
| Q34447423 | Prognostic molecular markers in non-small cell lung cancer |
| Q41766783 | Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators |
| Q53607547 | Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression |
| Q37519430 | Proteomic comparison of two-dimensional gel electrophoresis profiles from human lung squamous carcinoma and normal bronchial epithelial tissues |
| Q35869189 | Quantitative fluorescence in situ hybridization in lung cancer as a diagnostic marker |
| Q38009322 | RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome? |
| Q40762443 | Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis |
| Q34963435 | Smoking molecular damage in bronchial epithelium |
| Q24648133 | Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer |
| Q40707959 | Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro |
| Q31121564 | The Ras-association domain family (RASSF) members and their role in human tumourigenesis |
| Q74421009 | The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines |
| Q33846232 | Tumor progression and metastasis |
| Q44184282 | gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. |
| Q39124675 | hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression. |
Search more.